Clinical utility of targeted treatments in the management of epithelial ovarian cancer
Cheryl Twu,1 Ernest S Han21Department of Women’s Health, Arrowhead Regional Medical Center, Colton, CA, USA; 2Division of Gynecologic Oncology, City of Hope, Duarte, CA, USAAbstract: Epithelial ovarian cancer is typically found in its advanced stages, where a combination of surgical de...
Saved in:
Main Authors: | Twu C, Han ES |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/174964cf40d8465eaa72fc7fe6ebb42c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian cancer: emerging molecular-targeted therapies
by: Sourbier C
Published: (2012) -
Bevacizumab in the treatment of ovarian cancer
by: Ramez N Eskander, et al.
Published: (2011) -
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
by: Matthaiou EI, et al.
Published: (2014) -
Clinical utility of ramucirumab in advanced gastric cancer
by: Chan MMK, et al.
Published: (2015) -
STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/β-Catenin Signaling
by: Min Xie, et al.
Published: (2021)